Citrate during Donor Plasmapheresis

被引:0
|
作者
Evers, J. [1 ]
Taborski, U. [1 ]
机构
[1] Octapharma Plasma & Plasmazentrum Aachen, Helleter Feldchen 9, D-52146 Aachen, Germany
关键词
apheresis; citrate; citrate infusion rate; citrate toxicity; plasmapheresis;
D O I
10.1055/s-0042-100560
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We describe the distribution of trisodium-citrate 4% anticoagulant between the product and the donors undergoing plasma donation. The paper is based upon data of 32 regular donors of plasma initially collected for a study published in 2010 [1]. These data were re-analysed to determine the amount of citrate received by the donor and the citrate infusion rate in mg/kg/min to the donor [2]. Donor plasmaphereses were performed with the automated Haemonetics r PCS2. 130 +/- 12 ml trisodium-citrate 4% was used for 760ml plasma. An average of 110 ml trisodiumcitrate 4% was in collected plasma and not given to the donor. From the difference of 20 ml trisodium- citrate 4% an average citrate infusion rate of 0.16 mg/kg/min was calculated. It was concluded that the total amount of citrate anion received by the donor is only 514 mg and that the average citrate infusion rate of 0.16mg/kg/min is very low [2].
引用
收藏
页码:23 / 25
页数:3
相关论文
共 50 条
  • [31] A comparison of desensitization methods: Rituximab with/without plasmapheresis in ABO-incompatible living donor liver transplantation
    Eung Chang Lee
    Seong Hoon Kim
    Jae Ryong Shim
    Sang-Jae Park
    Hepatobiliary & Pancreatic Diseases International, 2018, 17 (02) : 119 - 125
  • [32] Factors associated with and predictive of persistence of donor-specific antibody after treatment with plasmapheresis and intravenous immunoglobulin
    Zachary, AA
    Montgomery, RA
    Leffell, MS
    HUMAN IMMUNOLOGY, 2005, 66 (04) : 364 - 370
  • [33] Citrate pharmacokinetics and calcium levels during high-flux dialysis with regional citrate anticoagulation
    Kozik-Jaromin, Justyna
    Nier, Volker
    Heemann, Uwe
    Kreymann, Bernhard
    Boehler, Joachim
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (07) : 2244 - 2251
  • [34] Assessment of complement activation during membrane-based plasmapheresis procedures
    Burnouf, T
    Eber, M
    Kientz, D
    Cazenave, JP
    Burkhardt, T
    JOURNAL OF CLINICAL APHERESIS, 2004, 19 (03) : 142 - 147
  • [35] Changes in serum cytokine levels during plasmapheresis in patients with myasthenia gravis
    Yeh, J. -H.
    Wang, S. -H.
    Chien, P. -J.
    Shih, C. -M.
    Chiu, H. -C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 (12) : 1318 - 1322
  • [36] Postnatal outcome and placental blood flow after plasmapheresis during pregnancy
    Jako, Maria
    Suranyi, Andrea
    Janaky, Marta
    Klivenyi, Peter
    Kaizer, Laszlo
    Vecsei, Laszlo
    Bartfai, Gyorgy
    Nemeth, Gabor
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2017, 30 (22) : 2755 - 2758
  • [37] A comparison of desensitization methods: Rituximab with/without plasmapheresis in ABO-incompatible living donor liver transplantation
    Lee, Eung Chang
    Kim, Seong Hoon
    Shim, Jae Ryong
    Park, Sang-Jae
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2018, 17 (02) : 119 - 125
  • [38] Low polymorphonuclear cell degranulation during citrate anticoagulation: A comparison between citrate and heparin dialysis
    Bos, JC
    Grooteman, MPC
    vanHoute, AJ
    Schoorl, M
    vanLimbeek, J
    Nube, MJ
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1997, 12 (07) : 1387 - 1393
  • [39] Arteriovenous access does not perform as well for plasmapheresis
    Wooster, Mathew
    Wilson, Rachel
    Shames, Murray
    Moudgill, Neil
    JOURNAL OF VASCULAR ACCESS, 2017, 18 (02) : 144 - 147
  • [40] Changing Trends in Therapeutic Plasmapheresis: An Indian Perspective
    Tiwari, Aseem K.
    Bhardwaj, Gunjan
    Aggarwal, Geet
    Arora, Dinesh
    Dara, Ravi C.
    Acharya, Devi P.
    Gayam, Sangeetha
    Choudhuri, Jui
    THERAPEUTIC APHERESIS AND DIALYSIS, 2017, 21 (05) : 500 - 506